CD40 and neoplasm: CAR-T cells expressing CD40 ligand (CD40L) can not only directly enhance the killing of CD40-positive tumor cells but also activate APCs and mobilize other endogenous immune cells to participate in anti-tumor responses and avoid tumor immune escape [157, 158].